Nicotinamide N-methyltransferase, which catalyzes methylation of niacinamide to generate 1-methylnicotinamide, has been proposed as a promising therapeutic target to prevent or treat obesity and diabetes [82,83]. This evidence concerns the gene NNMT and Obesity.